Forbes September 3, 2024
Enabling patients to order prescription medications directly from the drug maker is an emerging trend exemplified by the launch this year of two online platforms, LillyDirect and PfizerForAll, by Eli Lilly and Pfizer, respectively. Other pharmaceutical companies may follow suit. While these initiatives facilitate patient access to certain products, they also raise (ethical) questions concerning the possible disruption of established patient-physician relationships and the potential for conflicts of interest.
The drug maker Eli Lilly launched a site called LillyDirect in January that allows patients with diabetes, obesity and migraine to connect to telehealth providers and in-person referrals who can prescribe medications, which are then filled by third-party pharmacy dispensing services, such as Truepill or Amazon Pharmacy, and in the case...